Li Zhou

Tangshan People's Hospital — China

Medicine · Health Sciences

11h-index454citations50works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(15), Cancer Cells and Metastasis(9), Mass Spectrometry Techniques and Applications(8), T-cell and B-cell Immunology(7), Cell death mechanisms and regulation(6)

Publications50 total

Pan-cancer and multi-omics analyses reveal the diagnostic and prognostic value of BAZ2B in cancer
Scientific Reports·2026Open Access
Electrochemical sensor analyzing ANGPTL4 promotes M2 polarization of lung adenocarcinoma tumor-associated macrophages: inhibiting ferroptosis through the NF-κB-induced SLC7A11 transcription
Microchemical Journal·2026Open Access
Nonlinear relationship between BMI and 30-day in-hospital mortality in ICU sepsis patients: a multicenter retrospective cohort study
BMC Infectious Diseases·2025· 1 citedOpen Access
Association between platelet count and 30-day in-hospital mortality among intensive care unit patients with sepsis: a multicenter retrospective cohort study
Frontiers in Medicine·2025· 5 citedOpen Access
Platelet count has a nonlinear association with 30-day in-hospital mortality in ICU end-stage kidney disease patients: a multicenter retrospective cohort study
Scientific Reports·2024· 5 citedOpen Access
Association between baseline body mass index and 30-day in-hospital mortality among intensive care unit patients with sepsis: a multicenter retrospective cohort study
2024Open Access
Nonlinear relationship between platelet count and 30-day in-hospital mortality in ICU acute respiratory failure patients: a multicenter retrospective cohort study
European journal of medical research·2024· 11 citedOpen Access
FRI-500-YI ERAL1 down-regulates NADH: ubiquinone oxidoreductase core subunit V1 through N6-methyladenosine reader Insulin like growth factor 2 mRNA binding protein 2 to inhibit mitochondrial adenosine triphosphate synthesis and metastasis in hepatoma cells
Journal of Hepatology·2024
Platelet count has a nonlinear association with 30-day in-hospital mortality in ICU End- stage kidney disease patients: a multicenter retrospective cohort study
Research Square (Research Square)·2024Open Access
Nonlinear relationship between platelet count and 30-day in-hospital mortality in ICU acute respiratory failure patients: a multicenter retrospective cohort study
Research Square (Research Square)·2024Open Access
Table S1 from Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity
2023Open Access
Data from Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity
2023Open Access
Figure S5 from Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity
2023Open Access
Figure S3 from Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity
2023Open Access
Figure S5 from Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity
2023Open Access
Figure S2 from Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity
2023Open Access
Figure S4 from Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity
2023Open Access
Figure S1 from Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity
2023Open Access
Table S1 from Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity
2023Open Access
Figure S1 from Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Enrico L. DiGiammarino(25), Sun K. Ho(18), Mien Sho(18), Archana Thakur(18), C.M. Forsyth(18), Mengli Xiong(18), Siu Sze Tan(18), Melvin Fox(18), Belinda Cairns(18), Yoshiko Akamatsu(18), Diane Hollenbaugh(18), Hamsell M. Alvarez(18), David B. Powers(18), Zhenghai Xu(17), Josue Samayoa(17), Debra T. Chao(17), Vivian Zhao(16), Pan Zhou(7), Darren C. Phillips(6), Haichao Zhang(6)